Latest Articles
Endometriosis Treatment Market to Witness Massive Lucrative - openPR
Endometriosis Treatment Market to Witness Massive Lucrative openPR
Published: March 6, 2025, 5:32 a.m.
Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - Yahoo Finance
Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI Yahoo Finance
Published: March 4, 2025, 3:30 p.m.
Endometriosis Treatment Market to Witness Massive Growth by 2032 | Astra Zeneca Plc., Eli Lilly and Company - openPR
Endometriosis Treatment Market to Witness Massive Growth by 2032 | Astra Zeneca Plc., Eli Lilly and Company openPR
Published: March 4, 2025, 1:20 p.m.
Global Endometriosis Treatment Market to Reach USD 6,297.2 Million by 2035 at a 5.4% of CAGR - PharmiWeb.com
Global Endometriosis Treatment Market to Reach USD 6,297.2 Million by 2035 at a 5.4% of CAGR PharmiWeb.com
Published: Feb. 25, 2025, 4:05 p.m.
How Robotic Surgery is Transforming Endometriosis Treatment - Healthcare Radius
How Robotic Surgery is Transforming Endometriosis Treatment Healthcare Radius
Published: Feb. 7, 2025, 7:16 a.m.
Robotic surgery is revolutionizing endometriosis treatment and improving fertility: Experts - Healthcare Radius
Robotic surgery is revolutionizing endometriosis treatment and improving fertility: Experts Healthcare Radius
Published: Feb. 7, 2025, 7:16 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - EIN News
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR EIN News
Published: Jan. 21, 2025, 10:38 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire
Published: Jan. 21, 2025, 12:38 a.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
Link copied to clipboard!